相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。CO and bilirubin inhibit doxorubicin-induced cardiac cell death
Do-Sung Kim et al.
IMMUNOPHARMACOLOGY AND IMMUNOTOXICOLOGY (2009)
Targeting p38-MAPK in the ischaemic heart: kill or cure?
Rekha Bassi et al.
CURRENT OPINION IN PHARMACOLOGY (2008)
Heme-oxygenase-1-induced protection against hypoxia/reoxygenation is dependent on biliverdin reductase and its interaction with PI3K/Akt pathway
Alok S. Pachori et al.
JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY (2007)
Erythropoietin induces heme oxygenase-1 expression and attenuates oxidative stress
Pisut Katavetin et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2007)
Quercetin protects human hepatocytes from ethanol-derived oxidative stress by inducing heme oxygenase-1 via the MAPK/Nrf2 pathways
Ping Yao et al.
JOURNAL OF HEPATOLOGY (2007)
Endothelial nitric oxide synthase promotes neonatal cardiomyocyte proliferation by inhibiting tissue inhibitor of metalloproteinase-3 expression
Lamis Hammoud et al.
CARDIOVASCULAR RESEARCH (2007)
Triphlorethol-A induces heme oxygenase-1 via activation of ERK and NF-E2 related factor 2 transcription factor
Kyoung Ah Kang et al.
FEBS LETTERS (2007)
Erythropoietin protects cardiomyocytes from apoptosis via up-regulation of endothelial nitric oxide synthase
Dylan Burger et al.
CARDIOVASCULAR RESEARCH (2006)
Iron released by sodium nitroprusside contributes to heme oxygenase-1 induction via the cAMP-Protein kinase A-mitogen-activated protein kinase pathway in RAW 264.7 cells
HJ Kim et al.
MOLECULAR PHARMACOLOGY (2006)
Heme oxygenase-1/carbon monoxide: From basic science to therapeutic applications
SW Ryter et al.
PHYSIOLOGICAL REVIEWS (2006)
Heme oxygenase-1 gene activation by the NAD(P)H oxidase inhibitor 4-(2-aminoethyl) benzenesulfonyl fluoride via a protein kinase B, p38-dependent signaling pathway in monocytes
N Wijayanti et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
Erythropoietin protects the infant heart against ischemia-reperfusion injury by triggering multiple signaling pathways
P Rafiee et al.
BASIC RESEARCH IN CARDIOLOGY (2005)
Erythropoietin mimics ischemic preconditioning
JE Baker
VASCULAR PHARMACOLOGY (2005)
Erythropoietin prevents the acute myocardial inflammatory response induced by ischemia/reperfusion via induction of AP-1
T Rui et al.
CARDIOVASCULAR RESEARCH (2005)
Erythropoietin just before reperfusion reduces both lethal arrhythmias and infarct size via the phosphatidylinositol-3 kinase-dependent pathway in canine hearts
A Hirata et al.
CARDIOVASCULAR DRUGS AND THERAPY (2005)
Overexpression of heme oxygenase (HO)-1 renders Jurkat T cells resistant to Fas-mediated apoptosis: Involvement of iron released by HO-1
BM Choi et al.
FREE RADICAL BIOLOGY AND MEDICINE (2004)
Regulation of heme oxygenase-1 expression through the phosphatidylinositol 3-kinase/Akt pathway and the Nrf2 transcription factor in response to the antioxidant phytochemical carnosol
D Martin et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
Protein kinase Akt/PKB phosphorylates heme oxygenase-1 in vitro and in vivo
M Salinas et al.
FEBS LETTERS (2004)
Biliverdin therapy protects rat livers from ischemia and reperfusion injury
C Fondevila et al.
HEPATOLOGY (2004)
Erythropoietin mediates tissue protection through an erythropoietin and common β-subunit heteroreceptor
M Brines et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2004)
Cardioprotective effects of erythropoietin in the reperfused ischemic heart - A potential role for cardiac fibroblasts
CJ Parsa et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
Phosphatidylinositol-3-kinase signaling is required for erythropoietin-mediated acute protection against myocardial ischemia/reperfusion injury
ZQ Cai et al.
CIRCULATION (2004)
Timing of erythropoietin treatment for cardioprotection in ischemia/reperfusion
E Lipsic et al.
JOURNAL OF CARDIOVASCULAR PHARMACOLOGY (2004)
Hearts from rodents exposed to intermittent hypoxia or erythropoietin are protected against ischemia-reperfusion injury
ZQ Cai et al.
CIRCULATION (2003)
Recombinant human erythropoietin protects the myocardium from ischemia-reperfusion injury and promotes beneficial remodeling
L Calvillo et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)
Endothelial nitric-oxide synthase enhances lipopolysaccharide-stimulated tumor necrosis factor-α expression via cAMP-mediated p38 MAPK pathway in cardiomyocytes
TQ Peng et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
Role of heme oxygenase-1 in cardiovascular function
MA Perrella et al.
CURRENT PHARMACEUTICAL DESIGN (2003)
Expression of fatty acid binding proteins inhibits lipid accumulation and alters toxicity in L cell fibroblasts
BP Atshaves et al.
AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY (2002)
Development of heart failure and congenital septal defects in mice lacking endothelial nitric oxide synthase
QP Feng et al.
CIRCULATION (2002)
Carbon monoxide-releasing molecules - Characterization of biochemical and vascular activities
R Motterlini et al.
CIRCULATION RESEARCH (2002)
Nitric oxide and prostaglandin E-2 participate in lipopolysaccharide/interferon-gamma-induced heme oxygenase 1 and prevent RAW264.7 macrophages from UV-irradiation-induced cell death
YC Chen et al.
JOURNAL OF CELLULAR BIOCHEMISTRY (2002)
Endotoxin-induced mortality is related to increased oxidative stress and end-organ dysfunction, not refractory hypotension, in heme oxygenase-1-deficient mice
P Wiesel et al.
CIRCULATION (2000)
The p38 MAPK inhibitor, SB203580, abrogates ischaemic preconditioning in rat heart but timing of administration is critical
MM Mocanu et al.
BASIC RESEARCH IN CARDIOLOGY (2000)
Carbon monoxide generated by heme oxygenase 1 suppresses endothelial cell apoptosis
S Brouard et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2000)
Carbon monoxide has anti-inflammatory effects involving the mitogen-activated protein kinase pathway
LE Otterbein et al.
NATURE MEDICINE (2000)
Hypoxia differentially regulates stress proteins in cultured cardiomyocytes: Role of the p38 stress-activated kinase signaling cascade, and relation to cytoprotection
R Kacimi et al.
CARDIOVASCULAR RESEARCH (2000)